{
  "slug": "asher-biotherapeutics",
  "name": "Asher Biotherapeutics",
  "description": "Asher Biotherapeutics is pioneering cis-targeted immunotherapies that selectively activate specific immune cell types to achieve optimized efficacy and minimize toxicity, addressing shortcomings of conventional immunotherapies. Their lead molecule, etakafusp alfa (AB248), is a cis-targeted IL-2 designed for CD8+ effector T cells, showing initial evidence of anti-tumor activity.",
  "url": "https://optimly.ai/brand/asher-biotherapeutics",
  "websiteUrl": "https://asherbio.com/",
  "logoUrl": "https://logo.clearbit.com/asherbio.com",
  "baiScore": 52.5,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Oncology Immunotherapies",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-03T01:18:15.964Z",
  "verifiedVitals": {
    "website": "https://asherbio.com",
    "category": "Biotechnology",
    "what_it_does": "Asher Biotherapeutics is pioneering a new approach with cis-targeted immunotherapies that selectively activate only the immune cell types driving the desired therapeutic response. This innovation addresses shortcomings of conventional immunotherapies by engaging two molecules on the same immune cell, an immunomodulatory receptor and a specific target, to offer a new level of selectivity with optimized efficacy and minimized toxicity for cancer, autoimmune, and infectious diseases.",
    "primary_audience": "Patients and healthcare providers in need of more effective and less toxic cancer treatments.",
    "core_product": "The lead molecule in their pipeline is etakafusp alfa (formerly known as AB248), a cis-targeted IL-2 that specifically activates CD8+ effector T cells.",
    "named_competitors": [
      "Jazz Pharmaceuticals",
      "BeiGene",
      "Sana Biotechnology",
      "Accent Therapeutics",
      "ZaBeCor Pharmaceuticals"
    ]
  },
  "intentTags": null,
  "businessProfileClaims": [],
  "timestamp": 1789903996019
}